131I-meta-iodobenzylguanidine Scintigraphy of Neuroblastomas

Overview

Journal Semin Nucl Med

Specialty Nuclear Medicine

Date 1985 Apr 1

PMID 4001964

Citations 13

Authors

T MUNKNER

Affiliations

Soon will be listed here.

Abstract

Sixteen neuroblastoma patients have been studied by 131I-meta-iodobenzylguanidine (MIBG) scintigraphy. Three patients were possibly cured, and their scintigraphy results were normal. Thirteen patients had tumors and metastases demonstrated by 131I-MIBG, two of these patients had a normal vanillylmandelic acid (VMA) excretion level. One patient has been treated by 131I-MIBG, but died. 131I-MIBG was concentrated in other cells too, eg, in erythrocytes and platelets.

Citing Articles

Comparison of ¹²³I-metaiodobenzylguanidine (MIBG) and ¹³¹I-MIBG semi-quantitative scores in predicting survival in patients with stage 4 neuroblastoma: a report from the Children's Oncology Group.

Naranjo A, Parisi M, Shulkin B, London W, Matthay K, Kreissman S Pediatr Blood Cancer. 2011; 56(7):1041-5.

PMID: 21328522 PMC: 4581540. DOI: 10.1002/pbc.22991.

Nuclear medicine: metaiodobenzylguanidine in the diagnosis of pheochromocytoma and neuroblastoma.

Hattner R West J Med. 1988; 148(4):451.

PMID: 18750402 PMC: 1026138.

Neuroblastoma: evolving therapies for a disease with many faces.

Goldsby R, Matthay K Paediatr Drugs. 2004; 6(2):107-22.

PMID: 15035651 DOI: 10.2165/00148581-200406020-00004.

Iodine-131 metaiodobenzylguanidine scintigraphy for localization of lesions in children with neuroblastoma: comparison with computed tomography and ultrasonography.

Lastoria S, Maurea S, Caraco C, Vergara E, Maurelli L, Indolfi P Eur J Nucl Med. 1993; 20(12):1161-7.

PMID: 8299651 DOI: 10.1007/BF00171014.

Utility of thallium-201 and iodine-123 metaiodobenzylguanidine in the scintigraphic detection of neuroendocrine neoplasia.

Montravers F, Coutris G, Sarda L, Mensch B, Talbot J Eur J Nucl Med. 1993; 20(11):1070-7.

PMID: 8287875 DOI: 10.1007/BF00173485.